当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:85.10亿  总市值:85.10亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,436,562,723.527,527,509,548.095,427,084,311.733,396,883,405.31
  收到的税费返还35,986,090.2145,071,333.8124,236,162.881,119,091.25
  收到其他与经营活动有关的现金28,853,511.67167,204,666.3289,955,535.2967,922,075.13
  经营活动现金流入小计1,501,402,325.397,839,785,548.215,641,276,009.823,545,924,571.69
  购买商品、接受劳务支付的现金681,682,711.953,628,506,307.492,616,723,420.81,463,857,685
  支付给职工以及为职工支付的现金326,122,616.791,346,365,383.19960,271,911.27643,990,753.35
  支付的各项税费122,265,813.92489,651,459.12359,758,331.02271,039,830.51
  支付其他与经营活动有关的现金212,665,026.321,198,723,142.411,043,076,468.39675,538,245.92
  经营活动现金流出小计1,342,736,168.986,663,246,292.214,979,830,131.483,054,426,514.78
  经营活动产生的现金流量净额158,666,156.411,176,539,256661,445,878.34491,498,056.91
二、投资活动产生的现金流量:
  取得投资收益收到的现金-60,468,966.1560,293,032.860,000,000
  处置固定资产、无形资产和其他长期资产收回的现金净额40,200615,026.21303,2008,200
  投资活动现金流入小计40,20061,083,992.3660,596,232.860,008,200
  购建固定资产、无形资产和其他长期资产支付的现金122,790,203.99542,012,200.76380,002,187.69235,625,353.31
  投资支付的现金-300,000,000300,000,000-
  投资活动现金流出小计122,790,203.99842,012,200.76680,002,187.69235,625,353.31
  投资活动产生的现金流量净额-122,750,003.99-780,928,208.4-619,405,954.89-175,617,153.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金-385,000,000205,000,0007,000,000
  其中:子公司吸收少数股东投资收到的现金-380,000,000--
  取得借款收到的现金3,983,598,0008,777,750,0005,835,360,0003,490,450,000
  收到其他与筹资活动有关的现金-1,650,000,0001,020,000,0001,020,000,000
  筹资活动现金流入小计3,983,598,00010,812,750,0007,060,360,0004,517,450,000
  偿还债务支付的现金3,963,436,872.289,146,239,928.665,713,875,623.13,651,677,225.17
  分配股利、利润或偿付利息支付的现金72,482,112.84479,672,439.18391,711,985.74257,176,839.45
  其中:子公司支付给少数股东的股利、利润-66,830,370.9666,830,370.9665,332,037.63
  支付其他与筹资活动有关的现金284,667,947.641,572,101,962.131,087,423,793.361,122,652,095.72
  筹资活动现金流出小计4,320,586,932.7611,198,014,329.977,193,011,402.25,031,506,160.34
  筹资活动产生的现金流量净额-336,988,932.76-385,264,329.97-132,651,402.2-514,056,160.34
四、汇率变动对现金及现金等价物的影响-5,914,930.01477,331.533,040,427.583,877,130.09
五、现金及现金等价物净增加额-306,987,710.3510,824,049.16-87,571,051.17-194,298,126.65
  加:期初现金及现金等价物余额1,273,228,002.181,262,403,953.021,262,403,953.021,262,403,953.02
  期末现金及现金等价物余额966,240,291.831,273,228,002.181,174,832,901.851,068,105,826.37
补充资料:
  净利润-257,453,101.84-162,286,856.6
  资产减值准备--17,226,881.24--7,432,452.04
  固定资产和投资性房地产折旧-652,528,855.33-326,705,415.13
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-652,528,855.33-326,705,415.13
  无形资产摊销-241,809,700.87-115,523,593.12
  长期待摊费用摊销-14,569,081.94-6,695,415.43
  处置固定资产、无形资产和其他长期资产的损失--827,335.68-9,846.67
  固定资产报废损失--32.19--
  财务费用-361,548,158.82-190,640,852.41
  投资损失--60,625,000.37--26,285,765.54
  递延所得税--5,268,853.1--
  其中:递延所得税资产减少-23,283,851.89--
    递延所得税负债增加--28,552,704.99--
  存货的减少-118,902,218.35-201,726,632.27
  经营性应收项目的减少--197,849,078.66--658,708,576.05
  经营性应付项目的增加--283,443,368.66-118,609,973.78
  现金的期末余额-1,273,228,002.18-1,068,105,826.37
  减:现金的期初余额-1,262,403,953.02-1,262,403,953.02
  现金及现金等价物的净增加额-10,824,049.16--194,298,126.65
公告日期2026-04-252026-04-182025-10-252025-08-14
审计意见(境内)标准无保留意见
TOP↑